IL 'JET' URETERALE IN CORSO DI TRATTAMENTO MEDICO DELL'IPERTROFIA PROSTATICA BENIGNA

Translated title of the contribution: The urine flow jet in patients with benign prostatic hyperplasia under medical treatment

M. Sperandeo, A. Varriale, G. Sperandeo, E. Caturelli, M. Dragone

Research output: Contribution to journalArticle

Abstract

By Color-Doppler ultrasound it's possible to visualize urine flow from ureter into the bladder. Aim of the study was to image these ureteral jets in patients with benign prostatic hyperplasia (BPH) before and after therapy. Seven patients were studied, whose age ranged from 52 to 69 years; they were not affected by metabolic, hepatic, renal diseases and by prostate inflammation. A duplex scanner (Toshiba SSA 270 A) with a convex probe of 3.5 MHz was used. A transabdominal ultrasound study was performed, measuring prostate volume and imaging ureteral jet before and along a treatment (at four months intervals) with Finasteride 5 mg/die (Finastid, Neopharmed) and at the end of treatment. We found that the mean velocity of jets in patient affected by was higher than in healthy subjects (80 cm/sec vs 60 cm/sec) but during treatment it decreased along with symptom improvements and decreasing volume at US. We concluded that analysis of ureteral jets with Color-Doppler P.W. may add useful informations to real-time us in the study of patients affected by BPH undergoing treatment with Finasteride.

Translated title of the contributionThe urine flow jet in patients with benign prostatic hyperplasia under medical treatment
Original languageItalian
Pages (from-to)45-48
Number of pages4
JournalArchivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell"Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences
Volume66
Issue number4 SUPPL.
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The urine flow jet in patients with benign prostatic hyperplasia under medical treatment'. Together they form a unique fingerprint.

  • Cite this